UPC logo

UNIVERSE PHARMACEUTICAL-CL A

UPCNASDAQ
๐Ÿ† #4844 by market capUS Equity
$5.78โ–ผ $0.16 (โˆ’2.69%)
Live
1hโ€”
24hโ–ผ 2.7%
7dโ–ผ 4.5%
14dโ–ฒ 81.2%
30dโ–ฒ 30.5%
1yโ–ฒ 70.0%
๐ŸฆMarket Cap
$4M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-22.4%
Declining
๐Ÿ“ŠGross Margin
35.9%
Healthy
๐Ÿ’ตFCF Margin
-69.8%
Thin
โš–๏ธP/S Ratio
0.2x
Cheap
Otter Score
49
Weak

Trading Snapshot

Day Range
$5.70 โ€“ $5.82
52-Week Range
$2.00 โ€“ $17.96
Volume
$2.88B
Avg Volume
$3.47B
Shares Outstanding
631,761
Next Earnings
Oct 15, 2026

Fundamentals Snapshot

Annual Revenue
$18M
Last Q Revenue
$9M
P/E Ratio
-1.7
P/S Ratio
0.2x
EPS (TTM)
$-3.45
Dividend Yield
0.00%

Why Investors Own UPC

  • โœ“High-growth profile โ€” revenue up -7.5% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 37% gross margin and 15% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$18Mโ–ผ โˆ’11.2% YoY
Gross Margin (TTM)
36.9%โ–ฒ +2.7% YoY
Operating Income (TTM)
$5Mโ–ผ โˆ’11.2% YoY
Free Cash Flow (TTM)
$3Mโ–ผ โˆ’11.2% YoY

About UNIVERSE PHARMACEUTICAL-CL A

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
49/100

Analyst Price Target

โ“˜
Average Target
$7.41
โ–ฒ +28.2% Upside
High Target$8.51
Low Target$6.64
Based on 23 analysts

Latest News & Updates